Shares in Fisher Scientific rose 14.7 percent during the five-day trading period ended Tuesday, leading all gainers in the BCW Index. Fisher posted strong third-quarter results this past week, with revenue up 12.7 percent and profit more than doubling (see related article). Only one company in the Index, Qiagen, posted a decline for the past week, trading down 2.48 percent.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.